Clinical Trials and Regulatory Affairs in Drug Development

Clinical trials and regulatory affairs are fundamental components in the successful development and approval of pharmaceutical products, ensuring that drugs are safe, effective, and of high quality before reaching the market. This session focuses on the comprehensive processes involved in clinical research, including trial design, patient recruitment, data management, and ethical considerations. With increasing complexity in drug development, especially for biologics, personalized therapies, and rare diseases, there is a growing need for innovative clinical trial designs such as adaptive trials, decentralized trials, and real-world evidence-based studies. Regulatory affairs play a crucial role in guiding pharmaceutical companies through stringent approval pathways established by global regulatory authorities, ensuring compliance with international standards and guidelines. This session will explore evolving regulatory landscapes, harmonization efforts, and the impact of global regulations on drug approval and commercialization. Key topics include Good Clinical Practice standards, informed consent, patient safety monitoring, and the role of ethics committees in safeguarding participant rights. Additionally, the session will highlight the importance of efficient regulatory strategies, documentation, and submission processes that accelerate time-to-market while maintaining safety and efficacy. Emerging technologies such as digital data capture, remote monitoring, and artificial intelligence are transforming clinical trials by improving accuracy, reducing costs, and enhancing patient engagement. Challenges such as regulatory delays, data integrity issues, and cross-border trial management will also be addressed. This session provides valuable insights into how effective clinical and regulatory practices contribute to the development of innovative therapies and ensure that patients worldwide have access to safe and reliable medicines.

    Related Conference of Clinical Trials and Regulatory Affairs in Drug Development

    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    June 08-09, 2026

    20th World Drug Delivery Summit

    London, UK
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Clinical Trials and Regulatory Affairs in Drug Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in